ASRS 2024: A novel approach to myopic traction maculopathy

News
Video

Nikoloz Labauri, MD, FVRS, speaks about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy at ASRS 2024

At this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden, the Eye Care Network spoke with Nikoloz Labauri, MD, FVRS. Dr Labauri is the founder of DAVINCI Eye Clinic in Tbilisi, Georgia, and at the meeting, he appeared on an expert panel about myopic traction maculopathy. In this video, he discusses his presentation, "Suspensory Macular Buckling for Myopic Traction Maculopathy."

Editor's note: The below transcript has been lightly edited for clarity.

Nikoloz Labauri, MD, FVRS: Hi, I'm Dr Nikoloz Labauri from Tbilisi, Georgia and founder of DAVINCI Eye Clinic. Today I have spoken about the special technique for myopic traction maculopathy. So as we know, this is a disease, which comprises a large spectrum of complications, which certainly goes to the posterior pole of the eye. So this specific method is made specially to indent the posterior pole of the sclera. Today, we spoke about the six patients we have operated on plus 1 year, and the results were quite promising because, as the retinal detachments and macular holes since retinoschisis, which we had in our patients, all of them have vanished and all the holes were closed, and detached retinas were attached.

Compared to the traditional buckling devices, which we had before, this new technique actually suggests us much better results in terms of distorted vision and metamorphosia. The beauty of this buckling is that it indents a wider range, the wide surface of sclera. Instead of a dome shape indentation, it provides the flat shaped indentation. Another advantage is that it's just assembled before the implantation by the surgeon, so it doesn't need any specific custom makings and specific orders, so every surgeon has it in his or her OR. I have plenty of cases where ordering the traditional other types of [buckles] during this time period, this pathology, which is retinal detachment in high myopes, was progressing...until the devices were approaching the operating theatre.

Let's talk about the drawbacks and the dark side. The dark side of this technique is that it's a two-point fixation buckling, that it requires much much larger incisions. Instead of tugging teo muscles, we have to open the conjunctiva 360 and tuck all six muscles to slide the a buckle under the muscles, all the muscles except same medial rectus. In other words, we call it a wristwatch buckling, because indenting part is still placed exactly under the fovea, and around which covers, as I already mentioned, 7 millimeters of surface. It has a learning curve. It's the main disadvantage of this technique, and also it needs a larger incision.

Otherwise it offers a much higher satisfaction of our patients in terms of metamorphosia and distorted vision. Our results were very encouraging. However, we need larger numbers of study subjects and longer follow-up period. So I hope [to] come back with longer follow-up results by the next meeting. Thanks for having me.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.